Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of the Rechallenge Concept in Patients With BRAF-positive Anaplastic Thyroid Cancer After Progression on Anti-BRAF Therapy

NCT06362694 is registered in ClinicalTrials.gov with Saint Petersburg State University, Russia as lead sponsor.

NCT NCT06362694
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06362694 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of the Rechallenge Concept in Patients With BRAF-positive Anaplastic Thyroid Cancer After Progression on Anti-BRAF Therapy
Lead sponsor
Saint Petersburg State University, Russia
Phase
Phase 2
Overall status
Unknown status
Start date
March 25, 2024
Completion date
June 25, 2026
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anaplastic thyroid cancer